Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-20
2008-11-11
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S081000
Reexamination Certificate
active
07449476
ABSTRACT:
The invention encompasses a series of tetrahydrocarboline compounds of Formula I which inhibit HIV entry by attaching to the exterior viral envelop protein gp120 and interrupting the viral entry process, possibly by interfering with the cellular receptor CD4. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
REFERENCES:
patent: 6469006 (2002-10-01), Blair et al.
patent: 6476034 (2002-11-01), Wang et al.
patent: 6573262 (2003-06-01), Wallace et al.
patent: 6632819 (2003-10-01), Wang et al.
patent: 2005/0124623 (2005-06-01), Bender et al.
U.S. Appl. No. 10/762,108, filed Jan. 21, 2004, Tao Wang, et al.
Deon Daniel H.
Kadow John F.
Ruediger Edward H.
Bristol--Myers Squibb Company
Desai Rita J
Epperson James
LandOfFree
Tetrahydrocarboline antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrocarboline antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocarboline antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4033905